Stomatitis News and Research

RSS
Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Novel neutralizing antibodies targeting SARS-CoV-2 N-terminal domain discovered

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Different SARS-CoV-2 neutralization assays are reliable and concordant for antibody monitoring

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Nanoparticles with neutralizing antibodies can inactivate SARS-CoV-2

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

Spike-based DNA vaccine shows excellent protection against SARS-CoV-2 in a hamster model

How SARS-CoV-2 blocks immune response

How SARS-CoV-2 blocks immune response

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

Identifying SARS-CoV-2 spike protein mutations resistant to antibodies

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Antiviral inhibitor DDX42 shows broad activity against Chikungunya, HIV and SARS-CoV-2

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Furin cleavage site and D614G on SARS-CoV-2 spike evolved to balance infectivity, stability, cytopathicity

Study shows SARS-CoV-2 cell receptor is a novel target of the gamma-secretase enzyme complex

Study shows SARS-CoV-2 cell receptor is a novel target of the gamma-secretase enzyme complex

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental COVID-19 vaccine prevents severe disease in mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Experimental vaccine effective at preventing pneumonia in COVID-19-infected mice

Protein uses two different mechanisms to inhibit viral infections

Protein uses two different mechanisms to inhibit viral infections

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

New tools developed to test the ability of anti-coronavirus antibodies

New tools developed to test the ability of anti-coronavirus antibodies

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Single-dose Israeli vaccine candidate protective against SARS-CoV-2